Cargando…
Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells
The ubiquitin-proteasome and lysosome-autophagy pathways are the two major intracellular protein degradation systems that work cooperatively to maintain homeostasis. Proteasome inhibitors (PIs) have clinical activity in hematological tumors, and inhibitors of autophagy are also being evaluated as po...
Autores principales: | Zhu, Keyi, Dunner, Kenneth, McConkey, David J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809784/ https://www.ncbi.nlm.nih.gov/pubmed/19881538 http://dx.doi.org/10.1038/onc.2009.343 |
Ejemplares similares
-
Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors
por: Elshazly, Ahmed M., et al.
Publicado: (2023) -
Cytoprotective roles for autophagy
por: Moreau, Kevin, et al.
Publicado: (2010) -
EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotective Response in Human Lung Cancer Cells
por: Han, Weidong, et al.
Publicado: (2011) -
HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells
por: White, Matthew C., et al.
Publicado: (2018) -
The Cytoprotective Role of Autophagy in Response to BRAF-Targeted Therapies
por: Elshazly, Ahmed M., et al.
Publicado: (2023)